Assuring the quality of radio-labelled products from clinical trials to commercialisation

Thursday, July 2, 2020


Selcia’s BD Director (Technical Sales) will be presenting on the “Technical and quality challenges of preparing 14C-labelled API” as part of this online symposium organised by the Joint Pharmaceutical Analytical Group.

The use of radiolabelled materials in clinical trial, therapeutic and diagnostic applications presents many specialised challenges to assure their fitness for intended purpose. This symposium will examine the uses of radiolabelled materials, key regulatory requirements and best practices to assure their quality in clinical trials or commercialisation.

This symposium will be of interest to scientists and managers new to this field, or quality and regulatory professionals in the consultancy, industry or health service sectors looking to update their knowledge in the development, manufacturing, licensing and uses of radiolabelled products.

Eurofins Selcia are delighted to be supporting this event.

More info and registration here: